Literature DB >> 2779614

The effect of cigarette smoking on neutrophil kinetics in human lungs.

W MacNee1, B Wiggs, A S Belzberg, J C Hogg.   

Abstract

Neutrophils may play a part in the pathogenesis of the centrilobular emphysema associated with cigarette smoking. The capillary bed of the lungs concentrates neutrophils approximately 100-fold with respect to erythrocytes, producing a large pool of marginated cells. We examined the effect of cigarette smoking on the kinetics of this pool of cells, using 99mTc-labeled erythrocytes to measure regional blood velocity and 111In-labeled neutrophils to measure the removal of neutrophils during the first passage through the pulmonary circulation, their subsequent washout from the lungs, and the effect of local blood velocity on the number of neutrophils retained in each lung region. We observed no difference in these measurements between subjects who had never smoked (n = 6) and smokers who did not smoke during the study (n = 12). However, subjects who did smoke during the study (n = 12) had a significantly slower rate of washout of radiolabeled neutrophils from the lung (0.08 +/- 0.04 of the total per minute, as compared with 0.13 +/- 0.06 in smokers who did not smoke during the experiment and 0.14 +/- 0.08 in non-smokers) (P = 0.02). We also observed an increase in the regional retention of labeled neutrophils with respect to blood velocity in 5 of the 12 subjects who smoked during the study, but in none of the other subjects. We conclude that the presence of cigarette smoke in the lungs of some subjects increases the local concentration of neutrophils, and suggest that the lesions that characterize emphysema may be a result of the destruction of lung tissue by neutrophils that remain within pulmonary microvessels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779614     DOI: 10.1056/NEJM198910053211402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  59 in total

1.  Enhanced neutrophil response in chronic obstructive pulmonary disease.

Authors:  A Noguera; S Batle; C Miralles; J Iglesias; X Busquets; W MacNee; A G Agustí
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

Review 2.  Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema.

Authors:  J C Hogg; R M Senior
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 3.  Acute effects of cigarette smoke on inflammation and oxidative stress: a review.

Authors:  H van der Vaart; D S Postma; W Timens; N H T ten Hacken
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139

Review 4.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

Review 5.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

6.  Molecular multitasking in the airspace: alpha1-antitrypsin takes on thrombin and plasmin.

Authors:  Rubin M Tuder; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2007-05-31       Impact factor: 6.914

7.  Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

8.  Polymorphonuclear neutrophils move into the fast lane in chronic obstructive pulmonary disease.

Authors:  Takahiro Nakajima; Caroline A Owen
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

9.  Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitor.

Authors:  J I Weitz; E K Silverman; B Thong; E J Campbell
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 10.  General mechanisms of nicotine-induced fibrogenesis.

Authors:  Kendal Jensen; Damir Nizamutdinov; Micheleine Guerrier; Syeda Afroze; David Dostal; Shannon Glaser
Journal:  FASEB J       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.